ResApp (ASX:RAP) receives TGA approval for ResAppDx-EU version 2
- ResApp (RAP) has received Australian Therapeutic Good Administration (TGA) approval for version 2 of its smartphone app
- This app uses machine learning algorithms that analyse a patient's cough sounds to diagnose diseases and provide timely and accurate information
- Adults are now able to use the device to test for respiratory problems in addition to children and infants
- Forums
- ASX - By Stock
- RAP
- Receives TGA approval for ResAppDx-EU version 2
Receives TGA approval for ResAppDx-EU version 2
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online